IMCD IMCD N.V.

116.64USD106.35 EUR · AMS+0.42%Mkt Cap: 6.89B USDP/E: 27.48

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesive…

Institutional holders11 on file

Key Statistics

Company
Market Cap6.89B USD
Enterprise Value8.60B USD
Revenue (TTM)5.45B USD
Gross Profit1.31B USD
Net Income (TTM)238.64M USD
Revenue/Share92.33 USD
Last Price116.64 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5.2K
CountryNL
SectorBasic Materials
IndustrySpecialty Chemicals
ISINNL0010801007
Valuation
P/E (Trailing)27.48
P/E (Forward)16.13
PEG—
EV/EBITDA15.20
EV/Revenue1.58
P/S1.26
P/B2.96
EPS (TTM)4.24 USD
EPS (Forward)7.23 USD
52W Range
74.7499% of range117.19
52W High117.19 USD
52W Low74.74 USD
Profitability
Gross Margin24.98%
Oper. Margin8.07%
EBITDA Margin10.38%
Profit Margin4.55%
ROE10.66%
ROA4.69%
ROIC7.87%
ROCE10.31%
Growth
Revenue Growth6.60%
Earnings Growth10.00%
Cash Flow & Leverage
Operating CF353.47M USD
CapEx (TTM)22.27M USD
FCF Margin5.37%
FCF Yield4.25%
Net Debt1.71B USD
Net Debt/EBITDA3.02
Net Debt/FCF5.84
Balance Sheet
Debt/Equity0.84
Current Ratio1.35
Quick Ratio0.85
Book Value/Sh39.44 USD
Cash/Share4.62 USD
Dividends
Fwd Div Rate1.99 USD
Trail. Div Rate1.99 USD
Div. Yield1.71%
5Y Avg Yield1.42%
Payout Ratio46.53%
Ex-Div DateMay 5, 2026
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)130.13 USD
Upside (mean)+11.6%
Target Range87.74 USD – 164.52 USD
87.74+11.6% to mean164.52
# Analysts14
Ownership
Shares Out.59.03M
Float52.46M
Insiders0.98%
Institutions82.92%
Technical
SMA 50109.65 (+6.4%)
SMA 200100.73 (+15.8%)
Beta0.98
S&P 52W Chg12.00%
Avg Vol (30d)141.09K
Avg Vol (10d)149.46K
Technical Indicators
RSI (14)64.1
MACD1.5394
MACD Signal1.3767
MACD Hist.+0.1627
BB Upper117.74 USD
BB Middle113.39 USD
BB Lower109.04 USD
BB Width7.68%
ATR (14)2.350 USD
Vol Ratio (20d)1.23x

About IMCD (AMS: IMCD)

›

IMCD (AMS: IMCD) is listed on Euronext Amsterdam, where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 5,237 employees.

The shares were at 106.35 EUR on 19 November 2026, up 41.8% over 52 weeks. Its 52-week range is 68.14 EUR to 106.85 EUR, and it trades at the top of that range.

At a market capitalisation of 6.28B EUR, it trades at 27.5 times trailing earnings and 16.1 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 19% for IMCD. It pays a dividend yielding 1.71% (it pays out 47% of its earnings), against a median of 1.76% among the dividend payers in that peer group.

IMCD reports return on equity of 10.7%, an operating margin of 8.1% and revenue up 6.6% year over year.

Its debt exceeds its cash by 1.56B EUR, a debt-to-equity ratio of 0.84. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 118.64 EUR is 11.6% above the current price. The next earnings report is expected on 19 February 2027.